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Appraisal

Appraisal of Clinical Practice Guideline: Arthroscopic surgery for degenerative
knee arthritis and meniscal tears: a clinical practice guideline
Date of latest update: 2017. Date of next update: Not speciﬁed. Patient group:
Patients with degenerative knee disease, including those with or without radiographic evidence of osteoarthritis, mild to severe osteoarthritis, mechanical symptoms, acute onset knee pain, and meniscal tears. Intended audience: Patients with
degenerative knee disease and clinicians involved in their management. Additional
versions: In addition to this rapid recommendation published in the BMJ, a more
detailed version, including decision aids, is available from MAGICapp (www.
magicapp.org). Expert working group: The panel included orthopaedic surgeons,
a rheumatologist, physiotherapists, a general practitioner, general internists, epidemiologists, methodologists, and people with lived experience of degenerative
knee disease (including those who had undergone and those who had not undergone arthroscopy). Funded by: This guideline was not funded. Consultation with:
No mention of consultation beyond the working group. Approved by: Not speciﬁed.
Location: The guidelines and additional documents are available at: https://www.
bmj.com/content/357/bmj.j1982. Description and key recommendations: This
clinical practice guideline is presented as a BMJ rapid recommendation. The recommendations are based on two systematic reviews: one assessing the net beneﬁt
of knee arthroscopy compared with non-operative care and rate of complications;
and the other addressing what level of individual change is considered important to
patients – the minimum important difference. The summary guideline in the BMJ
uses infographics to simplify the key results, recommendations, absolute beneﬁts

and harms of arthroscopy, and key practical issues for both clinicians and patients.
The main objective of the guideline was to answer the clinical question: What is the
role of arthroscopic surgery in degenerative knee disease? The guideline makes a
strong recommendation against arthroscopic knee surgery in patients with
degenerative knee disease; strong recommendations favouring conservative management compared with surgery in patients with degenerative knee disease; and
that further research is unlikely to alter this recommendation. The GRADE approach
was used to rate the quality of evidence. Quality of evidence was rated as high for the
outcome of pain in the long term (1 to 2 years), and as moderate for the outcome of
function in the long term (1 to 2 years). The guideline concluded that compared with
conservative management there is no important beneﬁt of arthroscopic knee surgery for the outcomes of pain and function at 1 to 2 years follow-up. Harms associated with arthroscopic knee surgery were also investigated. Based on the low
quality available evidence, the rate of serious harms such as venous thromboembolism and infection were ﬁve and two per 1000 people, respectively.
Provenance: Invited. Not peer reviewed.
Goris Nazari and Joy MacDermid
Western University, London, Canada
https://doi.org/10.1016/j.jphys.2019.10.007

Appraisal of Clinical Practice Guideline: Centers for Disease Control and
Prevention Guideline on the Diagnosis and Management of Mild
Traumatic Brain Injury Among Children
Date of latest update: September 2018. Date of next update: Not stated. Patient group: Paediatric athletes who have sustained a mild traumatic brain
injury (sometimes known as concussion). Intended audience: Healthcare
professionals involved in the management of paediatric mild traumatic brain
injuries. Additional versions: This is the ﬁrst published version. Expert
working group: The Pediatric Mild Traumatic Brain Injury Guideline Workgroup as established by the Centers for Disease Control and Prevention (CDC).
This included a range of clinicians (eg, neurologists, neuropsychologists, athletic trainers, physiotherapists and emergency medicine physicians) representing various settings (eg, clinical, research, sports and education). Funded
by: The CDC provided complete ﬁnancial support for the evidence review and
to support the working group’s meetings. The CDC authors did not assist with
the development and preparation of the systematic review that underpinned
this guideline. Consultation with: Ad hoc experts were invited to provide
consultation, where necessary, to the workgroup. Approved by: The CDC authors reviewed and approved the present guideline for publication. Location:
The guideline and additional documents are available at: https://jamanetwork.
com/journals/jamapediatrics/fullarticle/2698456. Description and key recommendations: This clinical practice guideline was presented as a Journal of
the American Medical Association (JAMA) paediatrics special communication. The
recommendations are based upon a systematic review that aimed to answer six
clinical questions. The main objective of the review was to provide the ﬁrst broad
evidence-based guideline on the diagnosis and management of mild traumatic
brain injury in children aged  18 years. Findings from the review were synthesised into 46 recommendations (divided into 19 sets). Eleven recommendations pertained to diagnosis, 12 to prognosis and 23 to treatment/management.

Each recommendation was assigned a level of conﬁdence in the research (‘high’
to ‘very low’), and an indication of how often the recommendation should be
followed (‘almost always’ to ‘may sometimes’). A short summary of the evidence
follows each set of recommendations. The guideline recommends the use of the
term ‘mild traumatic brain injury’, as opposed to ‘concussion’ or ‘minor head
injury’, in order to remove different interpretations between families, researchers and healthcare professionals. Of interest to physiotherapists, the
guideline does not recommend the use of any imaging modality to diagnose mild
traumatic brain injury but does recommend using clinical decision rules and,
potentially, imaging to exclude intracranial injury (eg, subdural haemorrhage).
The strongest recommendations pertain to the education that patients and
families should receive following an instance of mild traumatic brain injury in
children. The working group recommend providing education about the warning
signs of more serious injuries, prevention of further injury, expected course of
recovery, instructions on monitoring symptoms, and management of mild
traumatic brain injury. The additional 22 treatment/management recommendations pertain to cognitive/physical rest, aerobic exercise, psychosocial support,
post-traumatic headache treatment, vestibulo-oculomotor dysfunction, sleep,
cognitive impairment and return to school.
Provenance: Invited. Not peer reviewed.
Prashant Jhala
Macquarie University, Australia
https://doi.org/10.1016/j.jphys.2019.11.003
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